Doctor profile · Federal record

Dr. Coleman Altman, D.O.

Dermatology Physician (CMS: Dermatology) · Charlotte, NC

  • NPI 1003806928
  • Accepts Medicare
  • MIPS 75.0 / 100 · 2023
  • 28 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
2630 E Seventh St, Suite 200
Charlotte, NC 282044318
(704) 364-6110
fax (704) 364-4245

Credentials & registration

NPPES · NUCC
NPI registered
October 2005 — 21 yrs on file
Profile last updated
April 29, 2014
Year of graduation
1998 — 28 yrs since
Specialty taxonomy
207N00000X — NUCC code
State license (1)
North Carolina #9900747

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1003806928. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
6,467
Distinct HCPCS
10
Medicare allowed
$395,819
HCPCS Description Services Patients Avg allowed
17003 Destruction of precancer skin growth, 2-14 growths 2,488 433 $6
17000 Destruction of precancer skin growth, 1 growth 776 595 $46
99213 Established patient office or other outpatient visit, 20-29 minutes 673 544 $85
99214 Established patient office or other outpatient visit, 30-39 minutes 599 490 $121
17110 Destruction of skin growth, 1-14 growths 434 364 $103
11102 Biopsy of related skin growth, first growth 406 348 $81
96900 Application of ultraviolet light to skin 259 17 $22
17004 Destruction of precancer skin growth, 15 or more growths 162 119 $159
11103 Biopsy of related skin growth, each additional growth 101 67 $47
11602 Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm 81 63 $117

In context: peer comparison

Among 23 peers in this city , average services per provider: 214. This provider delivers 30× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,656
Transactions
65
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
SUN PHARMACEUTICAL INDUSTRIES INC. 10 $198.40
Janssen Biotech, Inc. 6 $166.94
ABBVIE INC. 7 $151.09
E.R. Squibb & Sons, L.L.C. 7 $143.67
Amgen Inc. 5 $132.60
UCB, Inc. 4 $124.81
GENZYME CORPORATION 4 $114.70
Lilly USA, LLC 6 $97.09
LEO Pharma Inc. 3 $77.57
Boehringer Ingelheim Pharmaceuticals, Inc. 3 $71.38
Regeneron Healthcare Solutions, Inc. 2 $69.30
Fresenius Kabi USA, LLC 2 $49.18
Medimetriks Pharmaceuticals, Inc. 1 $45.62
PFIZER INC. 3 $43.00
Arcutis Biotherapeutics, Inc. 2 $27.49

By nature of payment

Food and Beverage
$1,591
Education
$65

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
552
Patients
326
Total drug cost
$14,032
Drug Type Claims Patients Total cost
Cephalexin Generic 132 102 $703
Triamcinolone Acetonide Generic 118 91 $1,221
Clobetasol Propionate Generic 51 37 $2,780
Doxycycline Hyclate Generic 46 20 $2,341
Ketoconazole Generic 33 20 $823
Clindamycin Hcl Generic 23 18 $164
Acyclovir Generic 20 0 $204
Clindamycin Phosphate Generic 18 12 $313
Metronidazole Generic 18 0 $1,678
Mupirocin Generic 18 0 $242

Frequently asked questions

Auto-generated from federal data
What is Dr. Coleman Altman's medical specialty?
Dr. Coleman Altman practices Dermatology Physician in Charlotte, NC.
Where does Dr. Coleman Altman practice?
Dr. Coleman Altman practices at 2630 E Seventh St, Charlotte, NC 282044318. Office phone: 7043646110.
What is Dr. Coleman Altman's NPI?
Dr. Coleman Altman's National Provider Identifier (NPI) is 1003806928, issued by NPPES.
Does Dr. Coleman Altman accept Medicare assignment?
Yes. Dr. Coleman Altman accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Coleman Altman commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Destruction of precancer skin growth, 1 growth (HCPCS 17000); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.